Spectrum Pharmaceuticals

.

FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

Orexigen Therapeutics Inc’s Anti-Obesity Drug Contrave, May Benefit Cardiovascul
Bad Weather and Labour Dispute at West Coast Ports Slow Auto industry But It Sti
In Order to Cut Costs, Target to Trim Thousands of Jobs
Lumber Liquidators Holdings Inc. say Their Products are Safe for Use, Stocks of
Online Pollution Documentary Gets Huge Audience in China in Just Two Days
Patrick Harker Named as Plosser’s successor by the Philadelphia Fed
Official manufacturing Index of China Moves Up
Walmart Wage Hike to Create a Ripple in the Other Industries
NXP Semiconductors to buy Smaller Peer Freescale Semiconductor
Minimum Wage for Tipped Workers Raised in New York
Office Depot and Home Depot Reports Better Than Expected Earnings Results
Attorney General Eric Schneiderman investigating the Selection Process of Casino
Syndicate content